Actualités

Mosaic posted a Q2 adjusted earnings beat, but weaker sales, lower volumes and higher sulfur costs hurt results as it cut 2026 capex guidance.

Microsoft stock is on a four-day winning streak after breaking out of a cup base at a pivot of 466.32 amid an earnings beat.

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

The company lifted its adjusted EBITDA guidance to $3.8 billion–$3.9 billion, crediting savings from last year's Skydance merger

Investing.com -- Shopify Inc. (NASDAQ: SHOP) reported second-quarter results that exceeded analyst expectations on both revenue and earnings, sending shares up 26% premarket as the company delivered accelerating growth across key metrics.

Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of -8.70% and -46.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NCR Voyix (VYX) delivered earnings and revenue surprises of +13.33% and +1.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

FTC Solar (FTCI) delivered earnings and revenue surprises of -55.10% and +6.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) delivered earnings and revenue surprises of +37.97% and +5.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Shopify stock tock soared as Q2 gross operating profit beat estimates amid worries over margin pressure from AI investments.

Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.

Investing.com -- Eli Lilly shares jumped more than 5% in premarket trading Wednesday after the U.S. pharma giant raised its annual revenue guidance amid strong demand for its popular weight-loss and diabetes drugs.

Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates

E-commerce platform Shopify (NASDAQ:SHOP) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 33.7% year on year to $3.58 billion. Its GAAP profit of $1.16 per share was significantly above analysts’ consensus estimates.

Uber stock fell after its Q2 results missed estimates for revenue and its growth forecast came up short of prior expectations.

Circle Internet Group, Inc. (CRCL) delivered earnings and revenue surprises of +12.50% and -5.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Industrials products and automation company Regal Rexnord (NYSE:RRX) missed Wall Street’s revenue expectations in Q2 CY2026 as sales rose 4.2% year on year to $1.56 billion. Its non-GAAP profit of $2.99 per share was 15.7% above analysts’ consensus estimates.

AMD stock fell on Wednesday as analysts said the stock had been priced for exceptional results.

AMD stock fell on Wednesday as analysts said the stock had been priced for exceptional results.

Investing.com -- Walt Disney Co (NYSE: DIS) shares rose 4.9% premarket after the entertainment giant reported third-quarter adjusted earnings that exceeded Wall Street expectations, though revenue came in slightly below estimates.

The ride-hailing company's bookings and earnings forecasts for the current quarter came in below analyst expectations

CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share

Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.

Ride sharing and on-demand delivery platform Uber (NYSE:UBER) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 12.2% year on year to $14.19 billion. Its non-GAAP profit of $0.81 per share was in line with analysts’ consensus estimates.

Clear Secure (YOU) delivered earnings and revenue surprises of +22.50% and +2.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NRG Energy (NYSE:NRG) reported second-quarter 2026 adjusted EBITDA of $1.2 billion, up 34% from a year earlier, while outlining plans for a 1.2-gigawatt Texas power plant intended to support a cloud and artificial intelligence hyperscaler’s data center load. President and Chief Executive Officer Ro

Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.

Kratos Defense & Security (NASDAQ:KTOS) shares jumped 7. 8% in pre-market trading after the defense technology company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations and raised its growth outlook for the full year.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 47.7% year on year to $22.97 billion. The company’s full-year revenue guidance of $86 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $8.38 per share was 27.3% above analysts’ consensus estimates.

Autonomous driving partner Wayve received a key London license, paving the way for public robotaxi trials on the platform.